𝔖 Bobbio Scriptorium
✦   LIBER   ✦

XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia

✍ Scribed by Vicent M. Guillem; Francisco Cervantes; Jesús Martínez; Alberto Alvarez-Larrán; María Collado; Mireia Camós; Anna Sureda; Margherita Maffioli; Isabel Marugán; Juan-Carlos Hernández-Boluda

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
124 KB
Volume
85
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe autoimmune hepatitis in a chronic
Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic response
✍ Steegmann, Juan Luis; Requena, María José; García-Buey, María Luisa; Granados, E 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 19 KB 👁 2 views

A patient with chronic myeloid leukemia (CML) treated with interferon alpha (IFN alpha) and who developed autoimmune hepatitis (AIH) is described. The patient was treated with IFN alpha 2a, a complete cytogenetic response was achieved 5 months later, and this response has lasted now more than 7 year

The relationship between telomere length
The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia
✍ Hiroshi Iwama; Kazuma Ohyashiki; Junko H. Ohyashiki; Shigefumi Hayashi; Ken Kawa 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## RESULTS. At the time of CML diagnosis, 19 patients had TRFs within the age-Medical College, Tokyo, Japan. matched normal range (mean { 2 1 standard deviation [SD]) and the remaining 2 Department of Cell Biology and Neuroscience, 25 patients had TRFs shorter than the age-matched normal range (õ